| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $36K | +145.2% |
| Cost of Revenue | $29K | +139.8% |
| Gross Profit | $8K | +167.4% |
| R&D Expense | $344K | +19.9% |
| SG&A Expense | $151K | +34.9% |
| Operating Income | -$2.5M | -0.6% |
| Interest Expense | $25K | +0.0% |
| Pre-tax Income | -$2.5M | +2.3% |
| Net Income | -$2.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | +6.2% |
| Accounts Receivable | $11K | — |
| Current Assets | $1.7M | +6.6% |
| Total Assets | $1.7M | +6.6% |
| Current Liabilities | $82K | -51.1% |
| Total Liabilities | $82K | -51.1% |
| Stockholders' Equity | $1.7M | +13.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -16.2% |
| Financing Cash Flow | $1.2M | -26.8% |
| +2.3% |
| EPS (Basic) | -$0.01 | +0.0% |